ONLINE SUBMISSION
  April, 2003

Chronic Renal Failure in Children

  S. Jamro, N. A. Channa, A. H. Shaikh, A. Ramzan  ( Department of Paediatrics, Chandka Medical College, Larkana and National Institute of Child Health*, Karachi. )
 

Introduction
In CRF there is irreversible and progressive loss of renal function with residual glomerular filtration rate (GFR) less than 30%. Metabolic disturbances occurring in CRF reflect an adaptation to the loss of renal function.1

The exact prevalence and incidence of CRF in children of Pakistan is not known but available figure suggest that it accounts for 10-12% of all renal cases.2 According to United States Renal Data System (USRDS), 20 new ESRD cases per million population of children per year are registered for renal replacement therapy.3

The goals of management of CRF in children is not only to prevent progression to ESRD but to fulfil the physiological and emotional needs of children to the best possible quality of life. These goals can be achieved by:

1. Early and appropriate treatment of reversible causes of CRF like vesicoureteric reflux (VUR), posterior uretheral valves (PUV) and urolithiasis.

2. Early and appropriate conservative management of CRF may help to achieve normal growth and development.

3. Periodic monitoring for rate of progression to end stage renal disease helps to plan for renal replacement therapy.3, 4
In Pakistan there are very few studies on chronic renal failure in children. Further more, there are very limited facilities for dialysis and renal transplant for children with ESRD. This study was planned with the objectives: (a) to determine the clinical presentation of CRF in Pakistani children and (b) to find out the etiology of CRF.


Patients and Methods
This is a descriptive prospective study of children of 1-12 years of age, attending children hospital, Chandka Medical College Larkana and National Institute of Child Health (Nephrology Unit) Karachi from January 1993 to December 1996.

Seventy eight cases, confirmed as CRF on the basis of residual glomerular filtration rate (GFR) less than 30% for more than 3 months were included in this study. Detailed history and thorough examination was done and recorded in a special proforma. Blood CP, urine analysis, blood urea, serum creatinine, serum electrolytes, serum calcium, serum phosphorus and alkaline phosphatase as well as X-ray hands, ultrasound for kidneys, ureters and bladder (KUB) were done in all cases. GFR was determined by the height/serum creatinine plotted on nomogram.5 Other specific tests like micturating cystourethrogram, intravenous pyelography, diethylene triamine pentacetic acid (DTPA) and dimercapto succinic acid (DMSA) renal nuclear scans, serum complement (C3) level, antinuclear antibodies (ANA), Anti double stranded DNA and renal biopsy were done when indicated to confirm the underlying cause.

Results
Seventy eight cases of CRF were included in the study. Majority (90%) were over 3 years of age with male to female ratio 1.8:1 (Table 1). Most common clinical presentations were anaemia, growth retardation and urinary complaints like dysuria, frequency of micturation, dribbling of urine and weak urinary stream (Table 2). Most common causes of CRF were reflux nephropathy, posterior uretheral valves, chronic glomerulonephritis and urolithiasis (Table 3).



Discussion
CRF is an irreversible progressive renal disorder, which ultimately leads to end stage renal failure (ESRF). Renal replacement therapy in the form of dialysis or renal transplant are the ultimate options for the management of these children. These treatment options are very costly and are available in only few centres in Pakistan. The age of presentation of CRF correlates closely with the underlying cause. CRF in children under 5 years of age is commonly the result of congenital nephropathies and obstructive uropathy, whereas after 5 years of age, acquired glomerular diseases (chronic glomerulo nephritis, haemolytic uremic syndrome) or hereditary disorders (Alport's syndrome, Juvenile nephronophthiasis) are common causes.6,7 Majority of the cases (64%) in our study presented after 6 years of age. There was a male predominance (M:F ratio 1.8:1) which may be due to little higher number of posterior urethral valves and Alport's syndrome. Anemia was invariably present in all cases (93.3%), which is similar to a study by Nawarro M. et al.8 Our children had more growth retardation (74.3%) as compared to 50% in Belts and Margrath Study.9 This may be due to late diagnosis and more prevalence of malnutrition in general population of our country. Hypertension with or without cardiac failure was found in 53.8% of cases, which is similar to 49% in Schorer's study.10

The most common primary cause leading to CRF in our study was reflux nephropathy (24.5%) which is similar to Indian (20%) and U.K (21%) studies.1,11 We had more cases of posterior uretheral valves (23%) as compared with Indian (7%) and U.K (12%) studies.1,11 This may be due to more referrals, as we are the only referral centers in Sindh and Balochistan with facilities of PUV fulguration. Chronic glomerulonephritis (15%) as a cause of CRF is similar to U.K (13%) and Indian (17%) studies.1,11 Urolithiasis (14%) was similar to the Indian study11 but there was no case reported in U.K study.1
The prevalence of congenital dysplasia/cystic renal diseases in this study is low as compared to other two studies, but it is comparable to figures of USA where polycystic kidney disease is responsible for 4.2% of ESRD in children.


Conclusion
The most common clinical presentation of CRF is anaemia, growth retardation, urinary complaints and hypertension in our study. The common cause of CRF include reflux nephropathy, posterior uretheral valves, chronic glomerulonephritis and urolithiasis in this study. Early diagnosis and management of these conditions may prevent or delay the progress to end stage renal disease. Preventable cause of CRF like VUR, PUV and urolithiasis should be detected early and managed promptly before they cause irreversible damage to kidneys.


Refrences
1. Fogo A, Ken U. Pathophysiology of Renal disease. In: Barrat TM, Avner ED, Harmon WE (eds). Pediatric nephrology 4th ed. Baltimore:. Lippincott Williams and Wilkins, 1999, pp. 1183-96.

2. Iqbal J, Rehman MA, Khan MA. Pattern of renal diseases in children. J Pak Med Assoc 1994;44:118-20.

3. Broyer M, Chantler C, Donckerwolke et al. The Paediatric registry of the European Dialysis and Transplant Association: 20 years experienc. Paediatr Nephrol 1993;7:758-68.

4. Wassner SJ, Baum M: Physiology and managemnet of chronic renal failure. In pediatric nephrology 4th ed. T. Mortin Barratt, Ellis D, Avner & William E Harmon (Eds). Lippincott Williams and Wilkins, Baltimore USA, 1999, pp. 1155-82.

5. Morris MC, Allanbay CW Toselant P, et al. Evaluation of height/ plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child 1981;58:611.

6. William DG. The cause of chronic renal failure. Med Int 1991;4:3563-5.

7. Bergstein JM. Renal failure. In: Nelson textbook of Paediatrics. 16th ed. Behrman RE, Kliegrman RN, Jenson HB (Eds). Philadelphia:W.B. Saunders, 2000, pp.1605-17.

8. Nawarro M.Alonso A, Avilla JM. Treatment of anaemia of CRF. Child Nephrol Urol 1991;11:146-51.

9. Betts PR, Margreth G. Growth pattern and dietry intake of children with chronic renal insufficiency. Br Med J 1974:2:189-197.

10. Schorer. H. Cardiovascular complications in CRF. Paediatr: Nephrol 2nd: ed: 1987, Eds Collin NVW. Baltimore: Williams and Wilkins 1987, pp. 773-98.

11. Srivastara RN. Epidemiology of renal disease in India: Paediat: Nephrol 2nd: 1987, Eds Collin NVW. Baltimore: Williams and Wilkin 1987, pp. 354-85.





News & Events

Dear Friends and Colleagues,
May you have a very Happy EID with your friends and Family.
May all of us be Blessed with peace and tranquility.
Let us all jointly say a prayer for all troubled persons all over the world
Warm regards,
Dr. Fatema Jawad
Editor-in-chief,
Journal of Pakistan Medical Association, Karachi
President, PAME
Pakistan Association of Medical Editors



WHO/GOARN Request for technical assistance for Cholera Control in Northern Iraq

Request for assistance

WHO is requesting assistance from GOARN partners to identify the following cholera and diarrhoeal diseases expertise to support the Ministry of Health of Iraq in cholera risk assessment and immediate preparedness activities to improve the health outcomes of the Syrian refugees current living in camps in the Kurdistan region of Iraq.

  • two (2) epidemiologists
  • two (2) clinical management experts
  • one (1) environmental health expert (WATSAN)
  • one (1)laboratory expert

Duration

6 day mission starting 13 June 2014 (this excludes travel time).

Location

Northern Iraq (Kurdistan region).

Language requirements

All candidates must be fluent in English- written, spoken and comprehension. Fluency in Arabic is an asset. Knowledge, abilities and skills All candidates are expected to demonstrate the following

  • Ability to conceptualize and promote innovative strategies and policies.
  • Ability to communicate and write in a clear concise manner, and to develop effective guidelines.
  • Excellent negotiation and interpersonal skills complemented by ability to motivate and lead others and to promote consensus. Tact, discretion and diplomacy
  • Demonstrated ability for project appraisal, project management, monitoring and evaluation and project impact assessment.
  • Ability to work with host governments and their agents, INGOs and national NGOs an advantage.
  • Proven experience of managing a large workload and multiple priorities.
  • Ability to work in difficult conditions.

Support to the mission

WHO/GOARN will cover the travel and per diem (to cover daily expense in the field) expenses for the duration of their mission. GOARN missions do NOT offer salary, consultancy fees or any other form of remuneration.

WHO will provide appropriate logistics support for the field mission. Pre-deployment orientation/training may be required at WHO.

Partners offers of assistance

Partners are requested to reply with offers of assistance, together with CVs and details of the availability of staff for this mission by email to goarn@who.int latest by 30 May 2014. Details of all offers from partners and eventual deployments will be maintained on the GOARN SharePoint.

Operational Contacts

Mamunur Malik WHO EMRO malikm@who.int

William Perea WHO HQ pereaw@who.int

Patrick Drury GOARN druryp@who.int



News



Index



Supplement